Retinoid therapy for psoriasis

Dermatologic Clinics

Volumn 22, Issue 4, 2004, Pages 467-476

  Yamauchi, Paul S ^a,b   Rizk, Dalia ^a   Lowe, Nicholas J ^a,b  

^a Clinical Research Specialists   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CALCIPOTRIOL; CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; ETRETIN; ETRETINATE; HYDROXYUREA; IMMUNOMODULATING AGENT; ISOTRETINOIN; METHOTREXATE; PSORALEN; RETINOID; TAZAROTENE; TRIAMCINOLONE ACETONIDE;

ALOPECIA; ARTHRALGIA; BLOOD TOXICITY; BONE MALFORMATION; BONE MARROW SUPPRESSION; BRAIN PSEUDOTUMOR; CARDIOVASCULAR MALFORMATION; CATARACT; CHEILITIS; CLINICAL TRIAL; CONGENITAL MALFORMATION; DERMATITIS; DESQUAMATION; DIPLOPIA; DRUG ACTIVITY; DRUG FORMULATION; DRUG MECHANISM; DRUG STRUCTURE; ENCEPHALOMENINGOCELE; EPISTAXIS; ERYTHEMA; EYE TOXICITY; FACE DYSMORPHIA; FETUS DISEASE; FOLLOW UP; HAIR LOSS; HUMAN; HYPERLIPIDEMIA; HYPEROSTOSIS; HYPERTRIGLYCERIDEMIA; LEUKOPENIA; LIVER TOXICITY; LOW SET EAR; MENINGOMYELOCELE; MENTAL DISEASE; MONOTHERAPY; MYALGIA; NAIL DYSTROPHY; NIGHT VISION; NONHUMAN; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PSORIASIS VULGARIS; PUSTULAR PSORIASIS; PUVA; REVIEW; RHINITIS; SIDE EFFECT; SKIN ABRASION; SKIN IRRITATION; TERATOGENICITY; TOXICITY; ULTRAVIOLET B RADIATION; VISUAL IMPAIRMENT; XEROPHTHALMIA; XEROSIS;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PROGNOSIS; PSORIASIS; PUVA THERAPY; RANDOMIZED CONTROLLED TRIALS; RETINOIDS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 4344582972     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(03)00126-8     Document Type: Review

References (43)

1. Moy R.L., Kingston T.P., Lowe N.J. Isotretinoin vs etretinate therapy in generalized pustular and chronic psoriasis. Arch Dermatol. 121:1985;1297-1301
2. Roenigk R.K., Gibstine C., Roenigk H.H. Jr. Oral isotretinoin followed by psoralens and ultraviolet A or ultraviolet B for psoriasis. J Am Acad Dermatol. 13:1985;153-155
3. Honigsmann H., Wolff K. Isotretinoin-PUVA for psoriasis. Lancet. 1:1983;236
4. Lowe M.N., Plosker G.L. Bexarotene. Am J Clin Dermatol. 1:2000;245-250
5. Wiegand U.W., Chou R.C. Pharmacokinetics of acitretin and etretinate. J Am Acad Dermatol. 39:1998;S25-S33
6. Jensen B.K., Chaws C.L., Huselton C.A. Clinical evidence that acitretin is esterified to etretinate when administered with ethanol [abstract]. FASEB J. 6:1992;A1570
7. Larsen F.G., Jakobsen P., Knudsen J., Weismann K., Kragballe K., Nielsen-Kudsk F. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol. J Invest Dermatol. 100:1993;623-627
8. McNamara P.J., Jewell R.C., Jensen B.K., Brindley C.J. Food increases the bioavailability of acitretin. J Clin Pharmacol. 28:1988;1051-1055
9. Chambon P. The retinoid signaling pathway: molecular and genetic analysis. Semin Cell Biol. 5:1994;115-125
10. Saurat J.H. Retinoids and psoriasis: novel issues in retinoid pharmacology and implications for psoriasis treatment. J Am Acad Dermatol. 41:1999;S2-S6
11. Chandraratna R.A. Tazarotene: first of a new generation of receptor-selective retinoids. Br J Dermatol. 49:1996;18-25
12. Ling M.R. Acitretin: optimal dosing strategies. J Am Acad Dermatol. 41:1999;S13-S17
13. Lowe N.J., Lazarus V., Matt L. Systemic retinoid therapy for psoriasis. J Am Acad Dermatol. 19:1988;186-191
14. Goldfarb M.T., Ellis C.N., Gupta A.K., Tincoff T., Hamilton T.A., Voorhees J.J. Acitretin improves psoriasis in a dose-dependent fashion. J Am Acad Dermatol. 18(suppl 4, pt 1):1988;655-662
15. Olsen E.A., Weed W.W., Meyer C.J., Cobo L.M. A double-blind, placebo-controlled trial of acitretin for the treatment of psoriasis. J Am Acad Dermatol. 21(suppl 4, pt 1):1989;681-686
16. Torok L., Kadar L., Geiger J.M. Acitretin treatment of severe psoriasis. Acta Dermatol Venereol Suppl (Stockh). 146:1989;104-106
17. Murray H.E., Anhalt A.W., Lessard R., et al. A 12-month treatment of severe psoriasis with acitretin: results of a Canadian open multicenter trial. J Am Acad Dermatol. 24:1991;598-602
18. Geiger J.M., Czarnetzki B.M. Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies. Dermatologica. 176:1988;182-190
19. Lassus A., Geiger J.M., Nyblom M., Virrankoski T., Kaartamaa M., Ingervo L. Treatment of severe psoriasis with etretin (Ro 10-1670). Br J Dermatol. 117:1987;333-341
20. Hoffman T.E., Watson W. Methotrexate toxicity in the treatment of generalized pustular psoriasis. Cutis. 21:1978;68-71
21. Tanew A., Guggenbichler A., Hönigsmann H., Geiger J.M., Fritsch P. Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study. J Am Acad Dermatol. 25:1991;682-684
22. Saurat J.-H., Geiger J.-M., Amblard P., Beani J.-C., Boulanger A., Claudy A., et al. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA, and placebo-PUVA in the treatment of severe psoriasis. Dermatologica. 177:1988;218-224
23. Laurahanta J., Geiger J.-M. A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis. Br J Dermatol. 121:1989;107-112
24. Muchenberger S., Schoff E., Simon J.C. The combination of oral acitretin and bath PUVA for the treatment of severe psoriasis. Br J Dermatol. 137:1997;587-589
25. Rosén K., Mobacken H., Swanbeck G. PUVA, etretinate, and PUVA-etretinate therapy for pustulosis palmoplantaris: a placebo-controlled comparative trial. Arch Dermatol. 123:1987;885-889
26. Parker S., Coburn P., Lawrence C., Marks J., Shuster S. A randomized double-blind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis. Br J Dermatol. 110:1984;215-220
27. Lawrence C.M., Marks J., Parkers S., Shuster S. A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis. Br J Dermatol. 110:1984;221-226
28. Ruzicka T., Sommerburg C., Braun-Falco O., Koster W., Lengen W., Lensing W., et al. Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis. Arch Dermatol. 126:1990;482-486
29. Lowe N., Prystowsky J.H., Bourget T., Edelstein J., Nychay S., Armstrong R. Acitretin plus UVB therapy for psoriasis: comparisons with placebo plus UVB and acitretin alone. J Am Acad Dermatol. 24:1991;591-594
30. Iest J., Boer J. Combined treatment of psoriasis with acitretin and UVB phototherapy compared with acitretin alone and UVB alone. Br J Dermatol. 120:1989;665-670
31. Scott L.J., Dunn C.J., Goa K.L. Calcipotriol ointment: a review of its use in the management of psoriasis. Am J Clin Dermatol. 2:2001;95-120
32. Ashcroft D.M., Li Wan Po A., Williams H.C., Griffiths C.E. Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability. Arch Dermatol. 136:2000;1536-1543
33. Iyer S., Yamauchi P., Lowe N.J. Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy. Br J Dermatol. 146:2002;118-121
34. Lowe N.J., David M. New retinoids for dermatologic diseases. Uses and toxicity. Dermatol Clin. 6:1988;539-552
35. Lebwohl M., Ali S. Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol. 45:2001;649-661
36. Weinstein G.D., Krueger G.G., Lowe N.J., Duvic M., Friedman D.J., Jegasothy B.V., et al. Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. J Am Acad Dermatol. 37:1997;85-92
37. Weinstein G.D., Koo J.Y., Krueger G.G., Lebwohl M.G., Lowe N.J., Menter M.A., et al. Tazarotene Cream Clinical Study Group Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. J Am Acad Dermatol. 48:2003;760-767
38. Lebwohl M.G., Breneman D.L., Goffe B.S., Grossman J.R., Ling M.R., Milbauer J., et al. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis. J Am Acad Dermatol. 39:1998;590-596
39. Gollnick H., Menter A. Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis. Br J Dermatol. 54:1999;18-23
40. Koo J.Y., Lowe N.J., Lew-Kaya D.A., Vasilopoulos A.I., Lue J.C., Sefton J., et al. Tazarotene plus UVB phototherapy in the treatment of psoriasis. J Am Acad Dermatol. 43:2000;821-828
41. Lowe N.J. Optimizing therapy: tazarotene in combination with phototherapy. Br J Dermatol. 54:1999;8-11
42. Koo J.Y. Tazarotene in combination with phototherapy. J Am Acad Dermatol. 39:1998;S144-S148
43. Behrens S., Grundmann-Kollmann M., Schiener R., Peter R.U., Kerscher M. Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel. J Am Acad Dermatol. 42:2000;493-495